Self-Reported Symptoms After Initiation of a Protease Inhibitor in HIV-Infected Patients and Their Impact on Adherence to HAART

REFERENCES

• Wainberg M, Friedland G. Public health implications of antiretroviral therapy and HIV drug resistance. JAMA. 1998;279:1977–1983.
   PubMed Web of Science ®Google Scholar
• Mehta S, Moore R, Graham N. Potential factors affecting adherence with HIV therapy. AIDS. 1997;11:1665–1670.
   PubMed Web of Science ®Google Scholar
• Lerner B, Gulick R, Dubler N. Rethinking non-adherence: Historical perspectives on triple-drug therapy for HIV dis-ease. Ann Intern Med. 1998;129:573–578.
   PubMed Web of Science ®Google Scholar
• Chesney MA, Morin M, Sherr L. Adherence to HIV combina-tion therapy. Soc Sci Med. 2000;50:1599–1605.
   PubMed Web of Science ®Google Scholar
• Crespo-Fierro M. Compliance/adherence and care manage-ment in HIV disease. AIDS Care. 1997;8:43–54.
   Google Scholar
• Carpenter C, Fischl M, Hammer S, et al. Antiretroviral therapy for HIV infection in 1997. Updated recommenda-tions of the International AIDS Society-USA panel. JAMA. 1997;278:1234–1235.
   Web of Science ®Google Scholar
• Deeks S, Smith M, Holodniy M, Kahn J. HIV-1 protease inhibitors. A review for clinicians. JAMA. 1997;277:145–153.
   PubMed Web of Science ®Google Scholar
• Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21–30.
   PubMed Web of Science ®Google Scholar
• Bangsberg D, Hecht F, Charlebois E, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14:357–366.
   PubMed Web of Science ®Google Scholar
• Kalichman SC, Ramachandran B, Catz S. Adherence to combination antiretroviral therapies in HIV patients of low health literacy. J Gen Intern Med. 1999;14:267–273.
   PubMed Web of Science ®Google Scholar
• Malow R, Baker S, Klimas N, et al. Adherence to complex antiretroviral therapies by HIV-positive drug abusers. Psychiatr Serv. 1998;49:1021–1024.
   PubMed Web of Science ®Google Scholar
• Gordillo V, del Amo J, Soriano V, Gonzalez-Lahoz J. Sociodemographic and psychological variables influencing adherence to antiretrovial therapy. AIDS. 1999;13:1763–1769.
   PubMed Web of Science ®Google Scholar
• Bangsberg D, Tulsky JP, Hecht FM, Moss AR. Protease inhibitors in the homeless. JAMA. 1997;278:63–65.
   PubMed Web of Science ®Google Scholar
• Moatti JP, Carrieri MP, Spire B, Gastaut JA, Cassuto JP, Moreau J. Adherence to HAART in French HIV-infected injecting drug users: The contribution of buprenorphine drug maintenance treatment. The Manif 2000 study group. AIDS. 2000;14:151–155.
   PubMed Web of Science ®Google Scholar
• van Roon E, VerzijI J, Juttmann J, Lenderink A, Blans M, Egberts A. Incidence of discontinuation of highly active antiretroviral combination therapy (HAART) and its determi-nants. J Acquir Immune Defic Syndr. 1999;20:290–294.
   Web of Science ®Google Scholar
• Flexner C. HIV-protease inhibitors. N Engl J Med. 1998;338:1281–1292.
   PubMed Web of Science ®Google Scholar
• Bassetti S, Battegay M, Furrer H, et al. Why is highly active antiretroviral therapy (HAART) not prescribed or discontin-ued? Swiss HIV cohort study. J Acquir Immune Defic Syndr. 1999;21:114–119.
   PubMed Web of Science ®Google Scholar
• Brundage MD, Pater JL, Zee B. Assessing the reliability of two toxicity scales: Implications for interpreting toxicity data. J Nat/ Cancer Inst. 1993;85:1138–1148.
   PubMed Web of Science ®Google Scholar
• Kastrissios H, Suarez J, Katzenstein D, Girard P, Sheiner L, Blaschke T. Characterizing patterns of drug-taking behavior with a multiple drug regimen in an AIDS clinical trial. AIDS. 1998;12:2295–2303.
   PubMed Web of Science ®Google Scholar
• Broers B, Morabia A, Hirschel B. A cohort study of drug users' compliance with zidovudine treatment. Arch Intern Med. 1994;154:1121–1127.
   PubMed Web of Science ®Google Scholar
• Morse E, Simon P, Coburg M, Hyssop N, Greenspan D, Belson P. Determinants of subject compliance within an experimental anti-HIV drug protocol. Soc Sci Med. 1991;32:1161–1167.
   PubMed Web of Science ®Google Scholar
• Eldred L, Wu A, Chaisson R, Moore R. Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease. J Acquir Immune Defic Syndr. 1998;18:117–125.
   Web of Science ®Google Scholar
• Klaus B, Grodesky M. Clinical implications of alcoholism in patients with HIV/AIDS. Nurse Pract. 1997;22:101–104.
   PubMedGoogle Scholar
• Haubrich RH, Little SJ, Currier JS, et al. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group. AIDS. 1999;13:1099–1107.
   PubMed Web of Science ®Google Scholar
• Sontag S. Illness As a Metaphor. New York: Farrar, Straus, & Giroux; 1978.
   Google Scholar
• Heitman E. The influence of values and culture in responses to suffering. In: Stark P, McGovern J, eds. The Hidden Dimension of Illness: Human Suffefing. New York: National League for Nursing Press; 1992:81–103.
   Google Scholar
• Myers L, Midence K. Adherence to treatment in medical conditions. The Netherlands: Harwood Academic; 1998.
   Google Scholar
• Muma R, Ross M, Parcel G, Pollard R. Zidovudine adher-ence among individuals with HIV infection. AIDS Care. 1995;7:439–447.
   PubMed Web of Science ®Google Scholar
• Lucas GM, Chaisson RE, Moore RD. Highly active antiretroviral therapy in a large urban clinic: Risk factors for virologic failure and adverse drug reactions. Ann Intern Med. 1999;131:81–87.
   PubMed Web of Science ®Google Scholar
• Macquart-Moulin G, Viens P, Bouscary M, et al. Discor-dance between physicians' estimations and breast cancer patients' self-assessment of side-effects of chemotherapy: An issue for quality of care. Br J Cancer. 1997;76:1640–1645.
   PubMed Web of Science ®Google Scholar
• da Silva FC, Fossa SD, Aaronson NK, et al. The quality of life of patients with newly diagnosed M1 prostate cancer: Expe-rience with EORTC clinical trial 30853. Eur J Cancer. 1996;32A:72–77.
   PubMed Web of Science ®Google Scholar
• Fontaine A, Larue F, Lassauniere JM. Physicians' recogni-tion of the symptoms experienced by HIV patients: How reliable? J Pain Symptom Manage. 1999;18: 263–270.
   PubMed Web of Science ®Google Scholar
• Chesney MA. Factors affecting adherence to antiretroviral therapy. Clin Infect Dis. 2000;30:S171–S176.
   PubMed Web of Science ®Google Scholar
• Demasi R, Tolson J, Pham S, et al. Self-reported adherence to HAART and correlation with HIV RNA: Initial results with the patient medication adherence questionnaire. Sixth Con-ference on Retroviruses and Opportunistic Infections; 1999; Chicago.
   Google Scholar
• Gifford AL, Bormann JE, Shively MJ, Wright BC, Richman DD, Bozzette SA. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. J Acquir Immune Defic Syndr. 2000;23:386–395.
   PubMed Web of Science ®Google Scholar
• Fallowfield L. Compliance issues in quality of life assess-ment: Experiences of two Cancer Research Campaign sponsored groups. Stat Med. 1998;17:541–546.
   PubMed Web of Science ®Google Scholar
• Moynihan C. Patient "non-compliance" and "missing data" in quality of life research: Where does the problem lie? Eur J Cancer. 1998;34:9-11.
   Google Scholar
• Carr A, Cooper D. Images in clinical medicine. Lipodystro-phy associated with an HIV-protease inhibitor. N Engl J Med. 1998;339:1296.
   PubMed Web of Science ®Google Scholar
• Knobel H, Carmona A, Lopez JL, et al. Adherence to very active antiretroviral treatment: Impact of individualized as-sessment. Enferm Infecc Microbiol Cl/n. 1999;17:78–81.
   PubMedGoogle Scholar
• Haynes R, McKibbon K, Kanani R. Systematic review of randomized trials of interventions to assist patients to follow prescriptions for medications. Lancet. 1996;100:258–268.
   Google Scholar
• Roberts KJ, Volberding P. Adherence communication: A qualitative analysis of physician-patient dialogue. AIDS. 1999;13:1771–1778.
   PubMed Web of Science ®Google Scholar
• Fuhrer F. La version frangaise de l'échelle CES-D. Descrip-tion and translation of the autoevaluation scale [in French]. Psychiatrie et Psychobiologie. 1989;4:163–166.
   Google Scholar